Brain and Central Nervous System Tumors Clinical Trials
There are 12 registered clinical trials for Brain and Central Nervous System Tumors in the TrialLens index.
Trials (12)
- Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors Phase 1 · National Cancer Institute (NCI)
- Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma Phase 2 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers N/A · Rutgers, The State University of New Jersey
- Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer N/A · Children's Oncology Group
- Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors Phase 1 · Darell D. Bigner, MD, PhD
- Etoposide in Treating Young Patients With Relapsed Ependymoma Phase 2 · Children's Cancer and Leukaemia Group
- Metabolic Syndrome in Childhood Cancer Survivors N/A · University of Minnesota
- Biological Therapy in Treating Patients With Primary or Advanced Glioma Phase 2 · Weill Medical College of Cornell University
- Proton Beam Radiation Therapy in Treating Young Patients Who Have Undergone Biopsy or Surgery for Medulloblastoma or Pineoblastoma N/A · Massachusetts General Hospital
- Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma Phase 2 · Duke University
- Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors Phase 1 · Pediatric Brain Tumor Consortium
- Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen Phase 2 · OHSU Knight Cancer Institute
Related landscapes
- N/A Brain and Central Nervous System Tumors
- Phase 2 Brain and Central Nervous System Tumors
- Phase 1 Brain and Central Nervous System Tumors
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.